Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/11/hive-digital-technologies-falls-4-amid-stonex-earnings-selloff.webp

Hive Digital Technologies Falls 4% Amid StoneX Earnings Selloff

TIM BOHEN•UPDATED NOV. 19, 2026, 12:30 PM ET
Reviewed by Jack Kelloggand Fact-checked by Jeff Zananiri

Hive Digital Technologies fell 4% alongside an earnings-related selloff elsewhere, but no operating link establishes fresh damage to its business.

HIVE Candlestick Chart

Get Free Alerts

Why HIVE Stock Is Falling Today

HIVE Digital Technologies last traded at $1.35 after the regular market closed, down 4% from the prior session’s close. StoneX, a financial-services company, also fell following its earnings call, but no established link connects that event to HIVE’s income. That leaves no supported earnings explanation for HIVE’s decline today.

What HIVE Digital Technologies Ltd Does

HIVE mines Bitcoin, using specialized computers to compete for rewards paid in the digital currency. It also rents computing capacity to customers running artificial-intelligence workloads. These businesses depend on different sources of demand, so a selloff elsewhere does not automatically weaken either operation.

HIVE Mining and Computing Revenue Drivers

Lower Bitcoin prices would reduce the value of HIVE’s mining rewards. Weaker demand for rented computers would pressure its computing business. Neither change is established for today’s session, so the decline alone cannot show whether pressure on earnings will last.

Quick Financial Overview

HIVE generates revenue but remains loss-making. It is a small-cap, meaning a smaller publicly traded company, with $373.8M in total stock-market value. It reported $150.0M in cash, cash equivalents, and short-term investments as of September 30, 2026, a balance covering cash, money readily turned into cash, and investments held for shorter periods.

HIVE Revenue and Accounting Loss

The latest quarter produced revenue of $84.9M alongside a net loss of $78.7M. That loss is the accounting shortfall after expenses, not the amount of cash spent. Sales therefore show an operating business, but they do not establish that its expansion pays for itself.

HIVE Construction and Financing Risks

Earlier commentary highlighted construction costs, financing execution and the timing of HIVE’s computing expansion as concerns. Higher building costs would increase the money needed before new capacity can earn revenue. These are background risks rather than newly announced setbacks today.

Get Free Alerts

HIVE Stock Is down 65% Over Six Months

HIVE is down 65% over six months, from around $3.75, leaving the shares near their annual low. The sustained decline matters more than treating this session as an isolated break. For perspective, the last daily move this large was three sessions ago.

Trading Perspective

The annual-high area in the mid $5s is a distant reference, not a price target. A lasting recovery would require the shares to stop setting lower trading levels; being near an annual low does not establish a bottom.

HIVE Expansion Timing Still Matters

A proposed computing-facility lease in Sweden still required a final agreement in the earlier earnings update. Financing and facility upgrades also remained conditions before the project could enter service. That makes completed agreements more useful evidence of progress than proposed revenue alone.

Get Free Alerts

Conclusion

The next relevant economic release has no established date here, so a dated market test cannot be named responsibly. Easier borrowing conditions could reduce the cost of HIVE’s planned facilities, while tighter conditions could make those projects more expensive to finance.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders